Suppr超能文献

使用遗传毒性测试国际研讨会(IWGT)和经济合作与发展组织(OECD)的标准对美国国家毒理学计划(NTP)小鼠淋巴瘤试验数据进行评估。

Evaluation of U. S. National Toxicology Program (NTP) mouse lymphoma assay data using International Workshop on Genotoxicity Tests (IWGT) and the Organization for Economic Co-Operation and Development (OECD) criteria.

作者信息

Schisler M R, Gollapudi B B, Moore M M

机构信息

The Dow Chemical Company, Midland, Michigan.

Exponent, Inc., Center for Health Sciences, Alexandria, Virginia.

出版信息

Environ Mol Mutagen. 2018 Dec;59(9):829-841. doi: 10.1002/em.22250. Epub 2018 Oct 25.

Abstract

The forward gene mutation mouse lymphoma assay (MLA) is widely used, as part of a regulatory test battery, to identify the genotoxic potential of chemicals. It identifies mutagens capable of inducing a variety of genetic events. During the 1980s and early 1990s, the U.S. National Toxicology Program (NTP) developed a publicly available database (https://tools.niehs.nih.gov/cebs3/ui/) of MLA results. This database is used to define the mutagenic potential of chemicals, to develop structure-activity relationships (SAR), and to draw correlations to animal carcinogenicity findings. New criteria for MLA conduct and data interpretation were subsequently developed by the International Workshop for Genotoxicity Testing (IWGT) and the Organization of Economic Cooperation and Development (OECD). These recommendations are included in a new OECD Test Guideline (TG490). It is essential that early experimental data be re-examined and classified according to the current criteria to build a curated database to better inform chemical-specific evaluations and SAR models. We re-evaluated more than 1900 experiments representing 342 chemicals against the newly defined acceptance criteria for background mutant frequency (MF), cloning efficiency (CE), positive control values (modified for this evaluation due to lack of colony sizing), appropriate dose selection, and data consistency. Only 17% of the evaluated experiments met all acceptance criteria used in this re-evaluation. Results from 211 chemicals were determined to be uninterpretable, 92 were positive, and 39 equivocal. The authors could not classify any responses as negative because colony sizing was not performed for any of these experiments and it is clear, based on many experiment with unacceptably low background and positive control MFs, that mutant colony recovery was often suboptimal. This re-evaluation provides a curated database for the MLA. A similar curation should be done for other widely used genetic toxicology assays, but will be more difficult for certain assays (e.g., in vitro chromosomal aberrations) because important parameters such as level of cytotoxicity were often not evaluated/reported. Environ. Mol. Mutagen. 59:829-841, 2018. © 2018 Wiley Periodicals, Inc.

摘要

正向基因突变小鼠淋巴瘤试验(MLA)作为一组法规测试的一部分被广泛应用,用于识别化学物质的遗传毒性潜力。它能识别出能够诱导多种遗传事件的诱变剂。在20世纪80年代和90年代初,美国国家毒理学计划(NTP)开发了一个可公开获取的MLA结果数据库(https://tools.niehs.nih.gov/cebs3/ui/)。该数据库用于定义化学物质的诱变潜力,建立构效关系(SAR),并与动物致癌性研究结果建立相关性。随后,遗传毒性测试国际研讨会(IWGT)和经济合作与发展组织(OECD)制定了MLA实施和数据解读的新标准。这些建议包含在新的OECD测试指南(TG490)中。必须根据当前标准重新审视早期实验数据并进行分类,以建立一个经过整理的数据库,从而更好地为特定化学物质的评估和SAR模型提供信息。我们根据新定义的背景突变频率(MF)、克隆效率(CE)、阳性对照值(由于缺乏集落大小测量,本次评估对此进行了修改)、合适的剂量选择和数据一致性的接受标准,对代表342种化学物质的1900多个实验进行了重新评估。在本次重新评估中,只有17%的评估实验符合所有接受标准。211种化学物质的结果被判定为无法解读,92种为阳性,39种为可疑。作者无法将任何反应归类为阴性,因为这些实验均未进行集落大小测量,而且基于许多背景和阳性对照MF低得不可接受的实验可以明显看出,突变集落回收率往往不理想。本次重新评估为MLA提供了一个经过整理的数据库。对于其他广泛使用的遗传毒性测试也应进行类似的整理,但对于某些测试(如体外染色体畸变测试)会更困难,因为细胞毒性水平等重要参数往往未被评估/报告。《环境与分子突变》59:829 - 841,2018年。© 2018威利期刊公司

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验